Cargando…
In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
Autores principales: | Cazzamalli, Samuele, Figueras, Eduard, Pethő, Lilla, Borbély, Adina, Steinkühler, Christian, Neri, Dario, Sewald, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644080/ https://www.ncbi.nlm.nih.gov/pubmed/31458304 http://dx.doi.org/10.1021/acsomega.8b03183 |
Ejemplares similares
-
In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin
Conjugate for the Treatment of Renal Cell Carcinomas
por: Cazzamalli, Samuele, et al.
Publicado: (2018) -
Linker Hydrophilicity Modulates the Anticancer Activity of RGD–Cryptophycin Conjugates
por: Anselmi, Michele, et al.
Publicado: (2020) -
Synthesis and Biological Characterization of Monomeric and Tetrameric RGD‐Cryptophycin Conjugates
por: Borbély, Adina, et al.
Publicado: (2020) -
Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery
por: Borbély, Adina, et al.
Publicado: (2019) -
Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
por: Borbély, Adina, et al.
Publicado: (2019)